Floatz logo

Cerebral Dopamine Neurotrophic Factor

Neuro-Degenerative Disease

Herantis Pharma Plc.Phase 1/2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

21 Active assets in the Neuro-Degenerative Disease cohort.

Asset / SponsorPhaseRating
Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules
Beijing Friendship Hospital
Phase 4BB
Live Combined Bifidobacterium
Beijing Friendship Hospital
Phase 4BB
Lipitor
Monash University
Phase 4BB
Acp-103
Vanderbilt University Medical Center
Phase 4BB
LEVODOPA
Merck Sharp & Dohme LLC
Phase 2B

View all 41 →

Same molecule, other indications

Cerebral Dopamine Neurotrophic Factor is also rated in:

movement disorderDormant
CCC
Indicative ·
55 / 100
View asset →
nervous system disorderDormant
CCC
Indicative ·
54 / 100
View asset →
brain disorderDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →